<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7198842\results\search\tropicalVirus\results.xml">
  <result pre="is permitted which does not comply with these terms. Abstract" exact="Chikungunya" post="disease (CHIKD) is a viral infection caused by an"/>
  <result pre="cell-mediated activation of B cells leads to the formation of" exact="CHIKV" post="specific antibodies. Increase in titres of neutralizing IgG/IgM antibodies"/>
  <result pre="and Biotechnology10.13039/100007675Core Fund fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction" exact="Chikungunya" post="disease (CHIKD), caused by an arthritogenic alphavirus, chikungunya virus"/>
  <result pre="several years (Figure 1). Figure 1 Sequence of events during" exact="CHIKV" post="infection: infected Aedes mosquito deposits the virus into the"/>
  <result pre="months/years. Acute Phase Early Events Leading to the Establishment of" exact="CHIKV" post="Infection The pre-acute phase or the incubation period of"/>
  <result pre="thus can react to the unprocessed antigens (43). Infection of" exact="CHIKV" post="in mice (footpad) led to a significant increase in"/>
  <result pre="immune response (39, 47, 51, 52). One such study of" exact="CHIKV" post="infection in mice models observed changes in cutaneous cytokine"/>
  <result pre="during early infection is evidenced by IFNAR-deficient mice models of" exact="CHIKV" post="infection in which mice died within 3 days post"/>
  <result pre="CHIKV infection in which mice died within 3 days post" exact="CHIKV" post="infection. Skin fibroblast cells upon infection by CHIKV virus"/>
  <result pre="days post CHIKV infection. Skin fibroblast cells upon infection by" exact="CHIKV" post="virus were found to be major producers of type"/>
  <result pre="infection, thus leading to a strong anti-viral defense early during" exact="CHIKV" post="infection (57). Establishment of the Acute Phase of Infection"/>
  <result pre="the local site of replication to the primary sites of" exact="CHIKV" post="infection in the host body (24). Hallmarks of the"/>
  <result pre="the NLR family were associated with peak inflammatory symptoms during" exact="CHIKV" post="infection and these effects could be reversed upon the"/>
  <result pre="or NLRP3 inhibitors (65). Previously, the role of inflammasomes in" exact="CHIKV" post="infection was explored through in-vitro studies using siRNA targeting"/>
  <result pre="in-vitro studies using siRNA targeting caspase-1 that showed enhancement in" exact="CHIKV" post="replication with silencing (66). Members of RIG-1-like helicase families"/>
  <result pre="stimulation with 5′-triphosphate RNA generates a robust antiviral response against" exact="CHIKV" post="through RIG-1 pathway with the help of transcription factor"/>
  <result pre="IFN-β, and TFN-α production (68). An association of TLR3 with" exact="CHIKV" post="replication was shown by an agonist of TRIF-dependent signaling"/>
  <result pre="controlling viral dissemination (57). Transcriptional analyses of peripheral blood from" exact="CHIKV" post="infected patients showed a high expression of viperin in"/>
  <result pre="and rapid immune response against the virus in permissive cells," exact="CHIKV" post="effectively evades the cellular control mechanisms. In fibroblast cells,"/>
  <result pre="evades the cellular control mechanisms. In fibroblast cells, for example," exact="CHIKV" post="dodges the interferon response by inducing a translational shut"/>
  <result pre="a translational shut off (27). Additionally, the cytopathic nature of" exact="CHIKV" post="induces apoptosis (72). Fibroblast and stromal cells, for example,"/>
  <result pre="vessels. Evidence has demonstrated the infection of blood monocytes by" exact="CHIKV" post="virus (75). The virus continues replication, achieving a peak"/>
  <result pre="viremia during the acute phase. Immunopathology of Acute Phase As" exact="CHIKV" post="infection spreads, host immune responses are activated by engaging"/>
  <result pre="CCR2−/− mice exhibited increased foot swelling and cartilage erosion upon" exact="CHIKV" post="infection (83). Macrophages are also known to be the"/>
  <result pre="(83). Macrophages are also known to be the reservoirs of" exact="CHIKV" post="in later stages of infection (24), which possibly plays"/>
  <result pre="neutrophil infiltration to the infected tissues (83). CCR2−/− mice upon" exact="CHIKV" post="infection showed enhanced arthritic symptoms without any significant change"/>
  <result pre="the key mediators of arthritic symptoms and tissue damage in" exact="CHIKV" post="infection by releasing granules carrying antimicrobial molecules and producing"/>
  <result pre="extracellular traps (NETs) through a process called NETosis. In vitro" exact="CHIKV" post="infection in neutrophils isolated from mice resulted in the"/>
  <result pre="viral load has been shown in IFNAR−/− mice model and" exact="CHIKV" post="infected patients, respectively, suggesting the anti-CHIKV role of NETosis"/>
  <result pre="cells, which secrete high levels of IFN-I (87, 88). In" exact="CHIKV" post="infection, the virus is sensed by pDCs in an"/>
  <result pre="inflammatory cytokine responses (89). Figure 2 Immune cell infiltration in" exact="CHIKV" post="infected tissues: the primary target organs during CHIKV infection"/>
  <result pre="infiltration in CHIKV infected tissues: the primary target organs during" exact="CHIKV" post="infection include liver, spleen, joints, and kidney. As the"/>
  <result pre="have recently been shown to contribute toward the pathogenesis during" exact="CHIKV" post="infection in mice without altering much of the viral"/>
  <result pre="of anti-CHIKV antibodies along with significantly reduced neutralizing activity (100)." exact="CHIKV" post="infected cells are killed by the induction of cytolytic"/>
  <result pre="cells may have a role in mediating cytolytic killing of" exact="CHIKV" post="infected cells during the acute phase of CHIKD (103)."/>
  <result pre="exhaustion during the later stages of the disease. Post-Acute Phase" exact="CHIKV" post="Clearance Clearance of CHIKV from blood paves the path"/>
  <result pre="stages of the disease. Post-Acute Phase CHIKV Clearance Clearance of" exact="CHIKV" post="from blood paves the path to recovery in CHIKD"/>
  <result pre="CHIKD. This phase is marked by complete clearance of active" exact="CHIKV" post="from the body by neutralizing antibodies in the blood"/>
  <result pre="and development of IgG antibodies with age. It suggests that" exact="CHIKV" post="neutralization and IgG titres were higher in 8-week-old mice"/>
  <result pre="were higher in 8-week-old mice during the acute phase, whereas" exact="CHIKV" post="clearance was not observed until post-acute phase in 20"/>
  <result pre="and persists for months or even years (108). Persistence of" exact="CHIKV" post="specific IgM antibodies in the blood and synovial fluid"/>
  <result pre="the major class of antibody produced in the case of" exact="CHIKV" post="infected mice model due to IFN-γ produced from CD4+"/>
  <result pre="Numerous reports have sought to characterize the neutralizing ability of" exact="CHIKV" post="specific antibodies, and it has been reported in mice"/>
  <result pre="immune cells (119). Administration of polyclonal anti-CHIKV virus antisera in" exact="CHIKV" post="infected RAG1−/− and B cell-deficient μMT mice resulted in"/>
  <result pre="(C3) (120–122). However, a recent study reports that clearance of" exact="CHIKV" post="and RRV remains unaffected in the C3−/− and B"/>
  <result pre="SR-A6 (MARCO) was identified as the key factor responsible for" exact="CHIKV" post="clearance (123). Disease Resolution Chikungunya disease resolution is a"/>
  <result pre="the key factor responsible for CHIKV clearance (123). Disease Resolution" exact="Chikungunya" post="disease resolution is a combination of viral clearance from"/>
  <result pre="inflammation (134). In the case of CHIKV, proteomic profiling of" exact="CHIKV" post="infected patients revealed a number of factors that mediate"/>
  <result pre="2 (TGFB2) are significantly downregulated mediators of inflammation found in" exact="CHIKV" post="patients with 1–10 days post-onset of symptoms (133). However,"/>
  <result pre="symptoms (133). However, a phase-specific analysis of these mediators in" exact="CHIKV" post="patients would provide better insight into the mechanism underneath"/>
  <result pre="insight into the mechanism underneath the resolution of inflammation upon" exact="CHIKV" post="infection. Also, RNA-seq analysis of feet and lymph nodes"/>
  <result pre="infection. Also, RNA-seq analysis of feet and lymph nodes of" exact="CHIKV" post="infected mice highlighted granzyme A as a major promoter"/>
  <result pre="(136). Macrophages exhibiting M2-like activation patterns are found in the" exact="CHIKV" post="induced musculoskeletal inflammatory lesions (138) and are known to"/>
  <result pre="the same time M2 macrophages might support the persistence of" exact="CHIKV" post="in the system leading to chronic disease. This hypothesis"/>
  <result pre="performed on a non-human primate model that suggests long term" exact="CHIKV" post="persistence in the macrophages (24). RNA interference (RNAi) controls"/>
  <result pre="and host immune factors (141–144). A recent report suggested that" exact="CHIKV" post="establishes infections by regulating miRNA expression profile (145). miR15,"/>
  <result pre="miR-16, miR-17, let-7e, miR-125, miR-99, and miR-23a are altered during" exact="CHIKV" post="infection which indicates that these act as biomarkers in"/>
  <result pre="receptor interactions, and Fc gamma R-mediated phagocytosis (145). In addition," exact="CHIKV" post="infection in human synovial fibroblasts triggers the expression of"/>
  <result pre="of NF-κB pathway by a negative feedback loop and promotes" exact="CHIKV" post="replication (147, 148). Likewise, miRNAs are also known to"/>
  <result pre="IL-1β, IL-6, and IL-17 associated with Th17 cells in both" exact="CHIKV" post="infected humans and CHIKD mice models (92, 93, 162,"/>
  <result pre="and CXCL-10 (26, 92, 103, 162, 179–182). At this stage," exact="CHIKV" post="virus particles/viral RNA is cleared from the blood; however,"/>
  <result pre="from the blood; however, studies have reported the persistence of" exact="CHIKV" post="RNA in the macrophages (24) and fibroblast during chronic"/>
  <result pre="Apart from RNA intermediates, studies have reported the persistence of" exact="CHIKV" post="specific proteins in host cells over an extended period"/>
  <result pre="(33), while in another study, CHIKV-capsid proteins were evident in" exact="CHIKV" post="infected mice as late as 60 days post-infection, suggesting"/>
  <result pre="may also be a contributing factor toward the persistence of" exact="CHIKV" post="(26). Another hallmark of the chronic phase is bone"/>
  <result pre="in the joints, osteoblast cells (Bone-forming cells) are susceptible to" exact="CHIKV" post="infection causing over-expression of IL-6 and RANKL and inhibition"/>
  <result pre="secrete enhanced levels of RANKL, IL-6, IL-8, and (MCP-1), upon" exact="CHIKV" post="infection resulting in higher RANKL: OPG ratio, which favors"/>
  <result pre="K, and β3 integrin. Secretion of IL-1 and TNF-α by" exact="CHIKV" post="infected resident macrophages phosphorylate JNK and ERK which in"/>
  <result pre="role of mosquito saliva is strikingly an understudied phenomenon in" exact="CHIKV" post="infection. Does the mosquito saliva possess factors that can"/>
  <result pre="does the presence of viral antibodies from previous bites affect" exact="CHIKV" post="pathogenicity during the next bite to a naïve individual?"/>
  <result pre="inflammation that have not been studied in the context of" exact="CHIKV" post="chronic infections. This review has strived to emphasize the"/>
  <result pre="zoonotic arbovirus. J Genrl Virol. (2007) 88:2363–77. 10.1099/vir.0.82858-017698645 4.Leparc-GoffartINougairedeACassadouSPratCde LamballerieX." exact="Chikungunya" post="in the Americas. Lancet. (2014) 383:514. 10.1016/S0140-6736(14)60185-924506907 5.RaoTRCareyDEPavriKM. Preliminary"/>
  <result pre="of La Reunion. PLoS Med. (2008) 5:e60. 10.1371/journal.pmed.005006018351797 24.LabadieKLarcherTJoubertCManniouiADelacheBBrochardPet al.." exact="Chikungunya" post="disease in nonhuman primates involves long-term viral persistence in"/>
  <result pre="host immune response. J Immunol. (2010) 184:5914–27. 10.4049/jimmunol.090025520404278 27.WhiteLKSaliTAlvaradoDGattiEPierrePStreblowDet al.." exact="Chikungunya" post="virus induces IPS-1-dependent innate immune activation and protein kinase"/>
  <result pre="of the T cell responses against E2, nsP1 and capsid" exact="CHIKV" post="proteins in recovered and chronic patients after the epidemics"/>
  <result pre="containing nonstructural protein 3. J Virol. (2018) 92:e00477–18. 10.1128/JVI.00477-1829875241 34.StaplesJEBreimanRFPowersAM." exact="Chikungunya" post="fever: an epidemiological review of a re-emerging infectious disease."/>
  <result pre="Topics in Neglected Tropical Diseases.Colombia: Intechopen (2019). p. 34–57. 38.PaulBJSadanandS." exact="Chikungunya" post="infection: a re-emerging epidemic. Rheumatol Ther. (2018) 5:317–26. 10.1007/s40744-018-0121-730047016"/>
  <result pre="Virology. (2014) 464:26–32. 10.1016/j.virol.2014.06.02325043586 40.StyerLMKentKAAlbrightRGBennettCJKramerLDBernardKA. Mosquitoes inoculate high doses of" exact="West Nile" post="virus as they probe and feed on live hosts."/>
  <result pre="with recombinant mosquito salivary protein D7 enhances mortality from subsequent" exact="West Nile" post="virus infection via mosquito bite. PLoS Neglect Trop Dis."/>
  <result pre="Hyg. (2008) 102:400–8. 10.1016/j.trstmh.2008.01.02418342898 51.StyerLMLimPYLouieKLAlbrightRGKramerLDBernardKA. Mosquito saliva causes enhancement of" exact="West Nile" post="virus infection in mice. J Virol. (2011) 85:1517–27. 10.1128/JVI.01112-1021147918"/>
  <result pre="of reemerging chikungunya virus. PLoS Pathog. (2007) 3:e89. 10.1371/journal.ppat.003008917604450 73.WikanNSakoonwatanyooPUbolSYoksanSSmithDR." exact="Chikungunya" post="virus infection of cell lines: analysis of the East,"/>
  <result pre="South African lineage. PLoS ONE. (2012) 7:e31102. 10.1371/journal.pone.003110222299053 74.Krejbich-TrototPGayBLi-Pat-YuenGHoarauJJJaffar-BandjeeMCBriantLet al.." exact="Chikungunya" post="triggers an autophagic process which promotes viral replication. Virol"/>
  <result pre="double-stranded (viral) RNA. J Immunol. (2004) 172:5656–63. 10.4049/jimmunol.172.9.565615100310 77.Dupuis-MaguiragaLNoretMBrunSLe GrandRGrasGRoquesP." exact="Chikungunya" post="disease: infection-associated markers from the acute to the chronic"/>
  <result pre="cell activation. J Infect Dis. (2011) 204:115–23. 10.1093/infdis/jiq00621628665 93.GardnerJAnrakuILeTTLarcherTMajorLRoquesPet al.." exact="Chikungunya" post="virus arthritis in adult wild-type mice. J Virol. (2010)"/>
  <result pre="infection in mice. J Immunol. (2013) 190:259–69. 10.4049/jimmunol.120217723209328 96.PanningMGrywnaKVan EsbroeckMEmmerichPDrostenC." exact="Chikungunya" post="fever in travelers returning to Europe from the Indian"/>
  <result pre="and Medicine. J Infect Chemother. (2011) 17:419–3. 10.1007/s10156-010-0124-y20862507 111.SchilteCStaikowskyFCoudercTMadecYCarpentierFKassabSet al.." exact="Chikungunya" post="virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS"/>
  <result pre="infection in human cells. PLoS ONE. (2013) 8:e79886. 10.1371/journal.pone.007988624278205 147.SelvamaniSPMishraRSinghSK." exact="Chikungunya" post="virus exploits miR-146a to regulate NF-κB pathway in human"/>
  <result pre="Role of proinflammatory cytokines and chemokines in chronic arthropathy in" exact="CHIKV" post="infection. Viral Immunol. (2011) 24:265–71. 10.1089/vim.2010.012321830898 163.NgLFChowASunYJKwekDJLimPLDimatatacFet al.. IL-1beta,"/>
  <result pre="184.DanksLTakayanagiH. Immunology and bone. J Biochem. (2013) 154:29–39. 10.1093/jb/mvt04923750028 185.AmdekarSParasharDAlagarasuK." exact="Chikungunya" post="virus-induced arthritis: role of host and viral factors in"/>
 </snippets>
</snippetsTree>
